Gastric Carcinoma — Trials

Gastric Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

586 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 183
Recruiting: 93
Ph III recruiting: 15
Growth YoY: +4.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–26 of 26 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07581405	GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer	not yet recruiting	Phase 2	26	University of Illinois at ChicagoOTHER	1	Aug 21, 2026	clinicaltrials
NCT07709767	Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma	not yet recruiting	Phase 2	21	Tang-Du HospitalOTHER	0	Jul 17, 2026	clinicaltrials